Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether treatment with a new drug called
ZK-Epothilone (ZK-Epo) in patients with metastatic breast cancer helps to decrease or stop
tumor growth.